Johnson & Johnson has been hit with a new crop of suits in federal court in Newark claiming its blockbuster drug Levaquin caused users to suffer nerve damage.

Between Aug. 1 and 11, the firm of Bernstein Liebhard has filed 13 Levaquin suits with 18 plaintiffs in the District of New Jersey against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals.